Last 1,360 INR
Change Today -5.70 / -0.42%
Volume 72.4K
CDH On Other Exchanges
Symbol
Exchange
Natl India
As of 11:37 AM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).

cadila healthcare ltd (CDH) Snapshot

Open
1,390
Previous Close
1,366
Day High
1,398
Day Low
1,351
52 Week High
10/21/14 - 1,398
52 Week Low
10/29/13 - 648.00
Market Cap
278.5B
Average Volume 10 Days
115.0K
EPS TTM
39.25
Shares Outstanding
204.7M
EX-Date
07/17/14
P/E TM
34.7x
Dividend
9.00
Dividend Yield
0.66%
Current Stock Chart for CADILA HEALTHCARE LTD (CDH)

Related News

No related news articles were found.

cadila healthcare ltd (CDH) Related Businessweek News

No Related Businessweek News Found

cadila healthcare ltd (CDH) Details

Cadila Healthcare Limited discovers, develops, manufactures, and markets a range of healthcare products worldwide. It provides its products in various forms, including formulations, injectable, aerosols, ointments, vaccines, biologics, active pharmaceutical ingredients, etc. The company offers products in the areas of cardiovascular, gastro intestinal, respiratory, women’s healthcare, pain management, CNS, anti-infective, oncology, neuroscience, dermatology, nephrology, and chronic/lifestyle primarily under the Aten, Ocid, Deriphyllin, Pantodac, Atorva, Nucoxia, and Mifegest brands. It also provides consumer healthcare and wellness products, such as Sugar Free Gold, a sweetener; Sugar Free Natura, a sucralose based sugar substitute; Sugar Free D’lite, a healthy drink; Nutralite, a cholesterol-free table spread; and Actilife, a nutritional milk additive for adults, as well as skincare products comprising scrubs, peel-off, face wash, and soaps under its Everyuth and Dermacare brands. In addition, the company researches and develops a pipeline of 19 biologics comprising 17 biosimilars and 2 novel biological products; new drugs in cardio-metabolic, inflammation, pain, and oncology therapeutic areas; novel drug delivery systems; molecules for DMF filing and NPD molecules; and generic products, as well as solid orals, pulmonary, parenterals, suppository, topical, and oncology products. Further, it provides animal healthcare products comprising drugs, feed supplements, and vaccines for livestock, companion animals, and poultry. Additionally, the company develops vaccines that are designed to address infectious diseases, including next-generation influenza, measles-mumps-rubella-varicella, typhoid, DPT-HiB, hepatitis-B, hepatitis-A, hepatitis-E, Japanese encephalitis, and HPV. It has strategic out-licensing deal with Abbott Laboratories for the commercial supply of products. The company was founded in 1952 and is headquartered in Ahmedabad, India.

Founded in 1952

cadila healthcare ltd (CDH) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

cadila healthcare ltd (CDH) Key Developments

Cadila Healthcare Limited Announces Consolidated Earnings Results for the Year of 2014

Cadila Healthcare Limited announced consolidated earnings results for the year of 2014. For the year, the company reported total income from operations of INR 72,240 million, EBIDT of INR 12,002 million, profit before tax of INR 9,594 million, net profit of INR 8,189 million and capex of INR 4,660 million.

Zydus Cadila Receives Tentative Approval for Glipizide ER Tablets

Zydus Cadila has received tentative approval from the USFDA to market Glipizide Extended release tablets in the strengths of 2.5 mg, 5 mg, and 10 mg. The drug falls in the ant-diabetic segment.

Zydus Receives Final Approval for Acyclovir Tablets

Zydus Cadila has received the final approval from the US FDA to market Acyclovir Tablets in the strengths of 400 mg and 800 mg. The drug falls under the anti-viral segment.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CDH:IN 1,360.10 INR -5.70

CDH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cipla Ltd/India 608.30 INR +4.05
Ipca Laboratories Ltd 684.85 INR +2.55
Piramal Enterprises Ltd 689.60 INR +6.60
Ranbaxy Laboratories Ltd 591.75 INR -1.85
Torrent Pharmaceuticals Ltd 828.65 INR +13.05
View Industry Companies
 

Industry Analysis

CDH

Industry Average

Valuation CDH Industry Range
Price/Earnings 32.7x
Price/Sales 3.6x
Price/Book 8.1x
Price/Cash Flow 26.0x
TEV/Sales 3.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CADILA HEALTHCARE LTD, please visit www.zyduscadila.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.